Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women

a meta-analysis

J. P. Ioannidis, T. A. Trikalinos, C. Zois, M. L. Brandi, L. Gennari, Omar Albagha, S Ralston, A. Tsatsoulis, I. Stavrou, ER-Alpha Genetics Meta-Analysis

    Research output: Contribution to journalArticle

    182 Citations (Scopus)

    Abstract

    The contribution of genetic polymorphisms to bone mineral density (BMD) and fracture risk in women is a controversial topic. We evaluated the effect of the XbaI and PvuII polymorphisms of the estrogen receptor a to BMD and fracture risk in a meta-analysis, including published data and additional information from investigators. Five thousand eight hundred thirty-four women from 30 study groups were analyzed with fixed and random effects models. The PvuII polymorphism was not associated with BNID at any skeletal site examined and 95% CIs exclude effects over 0.015 g/cm(2) for both the femoral neck and the lumbar spine. Conversely, XX homozygotes (women carrying two copies of the gene variant without an XbaI restriction site) consistently had higher BMD than other subjects. The magnitude of the effect was similar in the femoral neck and lumbar spine (0.014 g/cm(2) [95% CI, 0.003-0.025] and 0.015 g/cm(2) [95% CI, 0.000-0.030], respectively; no between-study heterogeneity for either). Total body BMD was also significantly higher in XX homozygotes (by 0.039 g/cm(2) and 0.029 g/cm(2) compared with Xx and xx, respectively). Available data on fractures suggested a protective effect for XX (odds ratio [OR], 0.66 [95% CI, 0.47-0.93] among 1591 women), but not PP (OR, 0.93 [95% CI, 0.72-1.18] among 2229 women). In summary, we have found that XX homozygotes may have higher BMD and also a decreased risk of fractures when compared with carriers of the x allele, whereas the PvuII polymorphism, is not associated with either BMD or fracture risk.

    Original languageEnglish
    Pages (from-to)2048-2060
    Number of pages12
    JournalJournal of Bone and Mineral Research
    Volume17
    Issue number11
    DOIs
    Publication statusPublished - 2002

    Keywords

    • bone mineral density
    • fractures
    • XbaI
    • PvuII
    • polymorphisms
    • estrogen receptor alpha
    • vitamin-D-receptor
    • hormone-replacement therapy
    • postmenopausal caucasian women
    • Chinese women
    • repeat polymorphism
    • genome screen
    • elderly women
    • hip fracture
    • genotypes
    • mass

    Cite this

    Ioannidis, J. P., Trikalinos, T. A., Zois, C., Brandi, M. L., Gennari, L., Albagha, O., ... ER-Alpha Genetics Meta-Analysis (2002). Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. Journal of Bone and Mineral Research, 17(11), 2048-2060. https://doi.org/10.1359/jbmr.2002.17.11.2048

    Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women : a meta-analysis. / Ioannidis, J. P.; Trikalinos, T. A.; Zois, C.; Brandi, M. L.; Gennari, L.; Albagha, Omar; Ralston, S; Tsatsoulis, A.; Stavrou, I.; ER-Alpha Genetics Meta-Analysis.

    In: Journal of Bone and Mineral Research, Vol. 17, No. 11, 2002, p. 2048-2060.

    Research output: Contribution to journalArticle

    Ioannidis, JP, Trikalinos, TA, Zois, C, Brandi, ML, Gennari, L, Albagha, O, Ralston, S, Tsatsoulis, A, Stavrou, I & ER-Alpha Genetics Meta-Analysis 2002, 'Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis', Journal of Bone and Mineral Research, vol. 17, no. 11, pp. 2048-2060. https://doi.org/10.1359/jbmr.2002.17.11.2048
    Ioannidis, J. P. ; Trikalinos, T. A. ; Zois, C. ; Brandi, M. L. ; Gennari, L. ; Albagha, Omar ; Ralston, S ; Tsatsoulis, A. ; Stavrou, I. ; ER-Alpha Genetics Meta-Analysis. / Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women : a meta-analysis. In: Journal of Bone and Mineral Research. 2002 ; Vol. 17, No. 11. pp. 2048-2060.
    @article{064a440a27394b4cace303257ac681fc,
    title = "Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis",
    abstract = "The contribution of genetic polymorphisms to bone mineral density (BMD) and fracture risk in women is a controversial topic. We evaluated the effect of the XbaI and PvuII polymorphisms of the estrogen receptor a to BMD and fracture risk in a meta-analysis, including published data and additional information from investigators. Five thousand eight hundred thirty-four women from 30 study groups were analyzed with fixed and random effects models. The PvuII polymorphism was not associated with BNID at any skeletal site examined and 95{\%} CIs exclude effects over 0.015 g/cm(2) for both the femoral neck and the lumbar spine. Conversely, XX homozygotes (women carrying two copies of the gene variant without an XbaI restriction site) consistently had higher BMD than other subjects. The magnitude of the effect was similar in the femoral neck and lumbar spine (0.014 g/cm(2) [95{\%} CI, 0.003-0.025] and 0.015 g/cm(2) [95{\%} CI, 0.000-0.030], respectively; no between-study heterogeneity for either). Total body BMD was also significantly higher in XX homozygotes (by 0.039 g/cm(2) and 0.029 g/cm(2) compared with Xx and xx, respectively). Available data on fractures suggested a protective effect for XX (odds ratio [OR], 0.66 [95{\%} CI, 0.47-0.93] among 1591 women), but not PP (OR, 0.93 [95{\%} CI, 0.72-1.18] among 2229 women). In summary, we have found that XX homozygotes may have higher BMD and also a decreased risk of fractures when compared with carriers of the x allele, whereas the PvuII polymorphism, is not associated with either BMD or fracture risk.",
    keywords = "bone mineral density, fractures, XbaI, PvuII, polymorphisms, estrogen receptor alpha, vitamin-D-receptor, hormone-replacement therapy, postmenopausal caucasian women, Chinese women, repeat polymorphism, genome screen, elderly women, hip fracture, genotypes, mass",
    author = "Ioannidis, {J. P.} and Trikalinos, {T. A.} and C. Zois and Brandi, {M. L.} and L. Gennari and Omar Albagha and S Ralston and A. Tsatsoulis and I. Stavrou and {ER-Alpha Genetics Meta-Analysis}",
    year = "2002",
    doi = "10.1359/jbmr.2002.17.11.2048",
    language = "English",
    volume = "17",
    pages = "2048--2060",
    journal = "Journal of Bone and Mineral Research",
    issn = "0884-0431",
    publisher = "WILEY-BLACKWELL",
    number = "11",

    }

    TY - JOUR

    T1 - Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women

    T2 - a meta-analysis

    AU - Ioannidis, J. P.

    AU - Trikalinos, T. A.

    AU - Zois, C.

    AU - Brandi, M. L.

    AU - Gennari, L.

    AU - Albagha, Omar

    AU - Ralston, S

    AU - Tsatsoulis, A.

    AU - Stavrou, I.

    AU - ER-Alpha Genetics Meta-Analysis

    PY - 2002

    Y1 - 2002

    N2 - The contribution of genetic polymorphisms to bone mineral density (BMD) and fracture risk in women is a controversial topic. We evaluated the effect of the XbaI and PvuII polymorphisms of the estrogen receptor a to BMD and fracture risk in a meta-analysis, including published data and additional information from investigators. Five thousand eight hundred thirty-four women from 30 study groups were analyzed with fixed and random effects models. The PvuII polymorphism was not associated with BNID at any skeletal site examined and 95% CIs exclude effects over 0.015 g/cm(2) for both the femoral neck and the lumbar spine. Conversely, XX homozygotes (women carrying two copies of the gene variant without an XbaI restriction site) consistently had higher BMD than other subjects. The magnitude of the effect was similar in the femoral neck and lumbar spine (0.014 g/cm(2) [95% CI, 0.003-0.025] and 0.015 g/cm(2) [95% CI, 0.000-0.030], respectively; no between-study heterogeneity for either). Total body BMD was also significantly higher in XX homozygotes (by 0.039 g/cm(2) and 0.029 g/cm(2) compared with Xx and xx, respectively). Available data on fractures suggested a protective effect for XX (odds ratio [OR], 0.66 [95% CI, 0.47-0.93] among 1591 women), but not PP (OR, 0.93 [95% CI, 0.72-1.18] among 2229 women). In summary, we have found that XX homozygotes may have higher BMD and also a decreased risk of fractures when compared with carriers of the x allele, whereas the PvuII polymorphism, is not associated with either BMD or fracture risk.

    AB - The contribution of genetic polymorphisms to bone mineral density (BMD) and fracture risk in women is a controversial topic. We evaluated the effect of the XbaI and PvuII polymorphisms of the estrogen receptor a to BMD and fracture risk in a meta-analysis, including published data and additional information from investigators. Five thousand eight hundred thirty-four women from 30 study groups were analyzed with fixed and random effects models. The PvuII polymorphism was not associated with BNID at any skeletal site examined and 95% CIs exclude effects over 0.015 g/cm(2) for both the femoral neck and the lumbar spine. Conversely, XX homozygotes (women carrying two copies of the gene variant without an XbaI restriction site) consistently had higher BMD than other subjects. The magnitude of the effect was similar in the femoral neck and lumbar spine (0.014 g/cm(2) [95% CI, 0.003-0.025] and 0.015 g/cm(2) [95% CI, 0.000-0.030], respectively; no between-study heterogeneity for either). Total body BMD was also significantly higher in XX homozygotes (by 0.039 g/cm(2) and 0.029 g/cm(2) compared with Xx and xx, respectively). Available data on fractures suggested a protective effect for XX (odds ratio [OR], 0.66 [95% CI, 0.47-0.93] among 1591 women), but not PP (OR, 0.93 [95% CI, 0.72-1.18] among 2229 women). In summary, we have found that XX homozygotes may have higher BMD and also a decreased risk of fractures when compared with carriers of the x allele, whereas the PvuII polymorphism, is not associated with either BMD or fracture risk.

    KW - bone mineral density

    KW - fractures

    KW - XbaI

    KW - PvuII

    KW - polymorphisms

    KW - estrogen receptor alpha

    KW - vitamin-D-receptor

    KW - hormone-replacement therapy

    KW - postmenopausal caucasian women

    KW - Chinese women

    KW - repeat polymorphism

    KW - genome screen

    KW - elderly women

    KW - hip fracture

    KW - genotypes

    KW - mass

    U2 - 10.1359/jbmr.2002.17.11.2048

    DO - 10.1359/jbmr.2002.17.11.2048

    M3 - Article

    VL - 17

    SP - 2048

    EP - 2060

    JO - Journal of Bone and Mineral Research

    JF - Journal of Bone and Mineral Research

    SN - 0884-0431

    IS - 11

    ER -